SCHEMBL32686773

SCHEMBL32686773

CC1c2ccc(Br)cc2C(=O)N1Cc1ccc2c(c1)oc(=O)n2COCC[Si](C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ TNIK Q9UKE5 8/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ MIF P14174 2/20 0.33
▸ TP53 P04637 1/20 0.32
▸ POLB P06746 2/20 0.32
▸ CBX7 O95931 1/20 0.31
▸ CDYL Q9Y232 1/20 0.31
▸ CDY1; CDY1B Q9Y6F8 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ CRHBP P24387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686806 0.93 NPC1 (0.39) NPC1ALDH1A1HPGDHTTKMT2A
SCHEMBL32686845 0.93 NPC1 (0.39) NPC1ALDH1A1HPGDHTTKMT2A
SCHEMBL32686871 0.93 NPC1 (0.39) NPC1ALDH1A1HPGDHTTKMT2A
SCHEMBL32686812 0.91 MIF (0.41) NPC1KMT2ATNIKMIFPOLB
SCHEMBL32686876 0.90 TNIK (0.36) NPC1ALDH1A1HTTKMT2ALMNA
SCHEMBL32686801 0.89 NPC1 (0.44) NPC1ALDH1A1HPGDHTTKMT2A
SCHEMBL31667561 0.87 NPC1 (0.37) NPC1HPGDKMT2ATNIKSIGMAR1
SCHEMBL31667152 0.87 NPC1 (0.46) NPC1ALDH1A1HTTKMT2ALMNA
SCHEMBL32686731 0.86 MIF (0.39) NPC1ALDH1A1HTTLMNATSHR
SCHEMBL32686769 0.86 TNIK (0.37) TNIKMIFTP53POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 NPC1 200/4885ALDH1A1 2719/4885HPGD 520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback